Greg Crawford: Sure. Yes. I think we are very confident about our liquidity at this point. We still have availability on our line of credit and that should be plenty for us to go through cash flow fluctuations we talked about. And as far, and apart from that to support our acquisition, we still have our ability on our DDTL. So between our ability on DDTL and the line of credit we feel like extremely comfortable with where we stand, not just to maintain what we have, but if we want to should continue on the acquisition path again, we don’t see a challenge of liquidity from that perspective.
Rahul Sarugaser: Terrific. That’s helpful. Thanks for taking our questions, I’ll get back in the queue now.
Operator: The next question comes from Tania Armstrong-Whitworth with Canaccord Genuity. Please go ahead.
Tania Armstrong-Whitworth: Good morning guys. Just following up on the questioning around bad debt, we can see a pretty market decline quarter-over-quarter. And I wonder if there were specific changes you made to your billing and collection process you can highlight for us.
Greg Crawford: Hi, good morning. Primarily in that it’s been our workflow processes in that, that we’ve improved on in that throughout 2022, and that we’re just starting to kind of see some of the reflective in that, of that work on the financials. So we would expect to see that to continue in that beyond this quarter.
Tania Armstrong-Whitworth: Okay. And where do you think that line item will settle as a percent of revenue then once all those changes are fully in effect?
Greg Crawford: Yes, we think consistently to stay in this, 5% to 7% range, I know kind of prior to this we were always 8% to 10% in that for bad debt. So we think now we can stay consistently 5% to 7%. That will depend on acquisitions also as we acquire companies and perhaps they don’t collect quite as good as we do in that it takes a while to implement that, but besides a larger one could potentially affect that.
Tania Armstrong-Whitworth: Okay, excellent. And when Great Elm is brought on, are they running at 5% to 7% bad debt expense as well, or is it a little bit higher and we may see that pick up in the interim?
Greg Crawford: Well, they are within a couple points of where we are on the lower side. So we don’t again, that’s why on the first question we said that what we currently have in Q1 can be considered as a good baseline, hopefully we’ll improve from here.
Tania Armstrong-Whitworth: Perfect. And then on Great Elm as well, I’m forgetting now if there are mixes between sales and rentals. Should we expect the gross margin to temporarily dip as you integrate Great Elm and get your patients onto your resupply business or will the Medicare changes kind of offset that and you can see gross merchants stay about the same?
Greg Crawford: Yes, so I guess, Great Elm does have a slightly different revenue versus sorry, revenue distinction between rentals and sales. So you would see a mathematical shift on the gross margin side. But if you look at, let’s say, if you look at gross margin as a cost of gross as a percentage of sales, we probably will still align between the two companies post close.
Tania Armstrong-Whitworth: Perfect. And then a bit different than we see in other healthcare companies where you typically see that Q4 seasonality, it doesn’t seem like your business has a ton of seasonality. Is that fair to assume?